Prof. Benny Zee 徐仲鍈教授

Director

Benny Chung-Ying Zee, PhD

Director, Office of Research and Knowledge Transfer Services; Professor/Head Division of Biostatistics, Director, Centre for Clinical Research & Biostatistics, Faculty of Medicine, Chinese University of Hong Kong

Prof. Benny Zee is the Director of the Office of Research and Knowledge Transfer Services (ORKTS), Director of the Centre for Clinical Research and Biostatistics (CCRB) and Professor of Jockey Club School of Public Health and Primary Care at the Chinese University of Hong Kong (CUHK). In addition, he holds honorary appointments in the Department of Clinical Oncology and the Department of Statistics of CUHK; he was the Chairperson of the Joint CUHK-NTEC Clinical Research Ethics Committee from 2006-2020. He is also the Director of the Clinical Trials and Biostatistics Lab at the CU Shenzhen Research Institute (SZRI).

Professor Zee obtained his PhD in Biostatistics from the University of Pittsburgh, USA, in 1987. He then joined the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG), currently known as the Canadian Cancer Trials Group (CCTG), as a Senior Biostatistician and faculty member in the Department of Community Health and Epidemiology and the Department of Mathematics and Statistics of Queen’s University Canada from 1987-2001. He remains an Adjunct Professor at Queen’s University after joining CUHK and actively promotes international academic activities and collaborations. 

Professor Zee is interested in multi-centre clinical trials, including statistical methods, data management, and drug and medical device development. He has experience developing efficient data management and “big data analytic” research using advanced computer technology. He also has ample experience working with the industry to design and carry out clinical trials that satisfy both academic interests and industry objectives. He has tremendous experience developing hospital infrastructures such as the Ethics Committee, GCP Centre and Risk-based Quality Assurance to conduct clinical research that meets regulatory and international requirements. He is also active in medical device development, such as “automatic retinal imaging analysis (ARIA)”, to assess the risk of stroke, dementia, diabetes and other chronic diseases. The technology has obtained patents from the USA, China and Taiwan and was commercialised through Health View Bioanalytic Limited with support from the Technology Start-up Support Scheme for Universities (TSSSU) of the Innovation Technology Commission (ITC). In addition, he is also active in bioinformatics research and co-founded Beth Bioinformatics Company Limited. He has published more than 304 international peer-reviewed journal articles. He serves on various committees, including advisory committees for drug development and data & safety monitoring committees for international drug trials.

徐仲鍈教授是香港中文大學研究及知識轉移服務處處長，賽馬會公共衛生及基層醫療學院教授，臨床研究及生物統計中心主任，及香港中文大學臨床腫瘤學和統計學系的名譽委任教授，同時任中文大學深圳研究院臨床試驗及生物統計實驗室主任。自2006-2020年，他是香港中文大學及醫管局新界東聯網臨床研究倫理委員會主席。

徐教授於1987年從美國匹茲堡大學獲得了生物統計學博士後，加入了加拿大國家癌症研究所的臨床試驗中心(NCIC CTG)任高級生物統計主任。從1987年至2001年，他在加拿大皇后大學 (Queen’s University Canada) 的社區衛生及流行病學系和數學及統計系任教。他加入香港中文大學之後，積極推動國際學術活動，仍然作為加拿大皇后大學的兼職教授。

徐教授對多中心臨床試驗擁有濃厚的興趣，其中包括統計方法，數據管理以及新藥及醫療器械的研發。他在高效率的數據管理程序方面有豐富的經驗，善於採用先進的計算機技術作「大數據分析」，在臨床試驗設計上，既能達到學術上的目標也能滿足業界的要求。徐教授在建立醫院管理結構上，尤其是在倫理委員會，國家藥物臨床試驗管理架構，以及建基於風險評估的質量管理上有豐富經驗，且能達至國際水平。他也投入醫療器械的研發，例如以「全自動視網膜圖像分析」評估中風風險、認知障礙風險及糖尿病風險等，該技術已獲美國、中國及台灣地區專利，且有賴於創新科技署(ITC) 的「大學科技初創企業資助計劃」資助，目前正通過康訊生物分析有限公司推出香港及國際市場。此外，他還積極從事生物信息學研究，共同創立了貝絲生物信息有限公司。徐教授發表了超過304篇國際論文，曾參與商界的藥物研發當顧問和統籌數據及安全監測小組。

Publications:

Scopus and Orcid

Scholar Mate

Google Scholars

ResearchGate

Other Information

LinkedIn